Literature DB >> 9784396

The hCSE1/CAS protein is phosphorylated by HeLa extracts and MEK-1: MEK-1 phosphorylation may modulate the intracellular localization of CAS.

U Scherf1, P Kalab, M Dasso, I Pastan, U Brinkmann.   

Abstract

hCSE1/CAS (CAS), the human homologue of the yeast chromosome segregation gene CSE1, is a nuclear transport factor that plays a role in proliferation and apoptosis. A MEK-1 phosphorylation sequence in CAS raises the possibility that MEK-phosphorylation regulates the function of CAS. CAS protein from cell extracts shows covalent charge modifications; one of these charge variants contains phosphotyrosine. CAS protein can be captured from cell extracts by immobilized anti-phosphotyrosine antibodies. We have produced recombinant protein fragments containing the N-terminal or central portion of CAS and found that the N-terminal fragment, which contains a putative MEK phosphorylation site, is phosphorylated by the HeLa extracts and MEK-1. Treatment of cells with an inhibitor of MEK-1 phosphorylation in vivo changes the intracellular localization of CAS from predominantly cytoplasmic to nuclear. This suggests that a function of CAS in nuclear transport may be regulated by phosphorylation. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784396     DOI: 10.1006/bbrc.1998.9367

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.

Authors:  Ming-Chung Jiang
Journal:  Tumour Biol       Date:  2016-09-05

2.  New methods for finding common insertion sites and co-occurring common insertion sites in transposon- and virus-based genetic screens.

Authors:  Tracy L Bergemann; Timothy K Starr; Haoyu Yu; Michael Steinbach; Jesse Erdmann; Yun Chen; Robert T Cormier; David A Largaespada; Kevin A T Silverstein
Journal:  Nucleic Acids Res       Date:  2012-01-12       Impact factor: 16.971

3.  Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts.

Authors:  Woan-Ruoh Lee; Shing-Chuan Shen; Yi-Hsien Shih; Chia-Lun Chou; Jonathan Te-Peng Tseng; Szu-Ying Chin; Kao-Hui Liu; Yen-Chou Chen; Ming-Chung Jiang
Journal:  J Transl Med       Date:  2015-06-13       Impact factor: 5.531

4.  Dissecting the signaling events that impact classical nuclear import and target nuclear transport factors.

Authors:  Mohamed Kodiha; Dan Tran; Andreea Morogan; Cynthia Qian; Ursula Stochaj
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.